问题我们的营销支出没效果 › B2B SaaS

我们的营销支出没效果
in B2B SaaS

大多数“没效果”的营销,是把钱花在无法触达买家的渠道上,而且衡量方式也看不出问题。 B2B SaaS公司遇到的版本不是通用问题。增长已从42%降到32%,而60%的收入集中在经济性最差的细分里,因此忽略净收入留存的答案必然错误。分析必须从各细分的CAC回本期和ACV入手,而不是从收入开始。

简短回答

大多数“没效果”的营销,是把钱花在无法触达买家的渠道上,而且衡量方式也看不出问题。 B2B SaaS公司遇到的版本不是通用问题。增长已从42%降到32%,而60%的收入集中在经济性最差的细分里,因此忽略净收入留存的答案必然错误。分析必须从各细分的CAC回本期和ACV入手,而不是从收入开始。

两种不同失败会产生同样的抱怨。渠道确实触达不到你的买家,这时增加预算只会更糟。或者渠道能触达但你看不见,这时支出就被无法追踪买家实际路径的衡量系统评判。

区分两者首先是衡量问题。如果无法按渠道算出获客成本,再多的创意或定向调整也解决不了争论,预算就会被最自信的人分配。

第二个问题是回本期而非量。一个获客贵但在一个季度内回本的渠道可以继续投入;一个获客便宜但三年才回本的渠道则不行,无论线索成本怎么说。

如何判断这确实是你的问题

这三者同时出现才是标志。单独一个通常指向其他问题。

✓ 无法按渠道说明获客成本
✓ 支出用展示量、点击或线索而非客户来辩护
✓ 表现最好的渠道随汇报人不同而变化

通常会让情况更糟的做法。 在修复衡量前先优化创意和定向,导致用不可靠数字做一整年自信决策。

Who this is for — and who it is not

It is for you if you run or finance a B2B SaaS company and cost per acquisition cannot be stated by channel. It is the situation where the numbers are available but nobody has put them in an order that produces a decision.

It is not for you if Percision is the wrong tool if you already know the answer and only need execution capacity, or if the business is pre-revenue — then the constraint is evidence about the market, not analysis of your own figures. Percision is not a lawyer, tax advisor, auditor, licensed appraiser, clinical or regulatory filer, or an AI implementation shop. It does not do HR casework, creative-only brand work, or impersonate a named consulting firm. It is a strategy analysis engine — not a template library. Also wrong if you need facilitation, politics, or someone to sit with a lender or buyer. Those are human jobs.

Percision is not a lawyer, tax advisor, auditor, licensed appraiser, clinical or regulatory filer, or an AI implementation shop. It does not do HR casework, creative-only brand work, or impersonate a named consulting firm. It is a strategy analysis engine — not a template library.

实际运行分析时的样子

Below is an excerpt from a real run of this analysis on 一家B2B SaaS公司. It is a sample profile rather than a customer, and it is engine output translated from English — this is the format you get, on your own numbers.

The subject is TechNova Solutions, a sample company profile used for testing rather than a customer — $45M ARR, 280 engineers.

Excerpt from a real Percision run · Pricing Strategy · sample company profile

The move. Turn the 11-week implementation backlog into 50 reusable modules that lift services gross margin from 41 % to 55 % while preserving 23 % win rate.

What the run committed to
Investment required$3.0-4.2 M total over 36 months
Expected returnBase case 3.8× cash-on-cash within 36 months
Revenue, year 1$47.8-49.2 M ARR
Revenue, year 2$51.5-54.0 M ARR
Revenue, year 3$56.0-60.0 M ARR
Exit criteriaStrategy abandoned if, by Month 12, template-able rule rate remains below 40 % OR if NRR of pilot cohort falls below 85 %; capital reallocated to Segment 2 analytics bolt-on.

This is one move out of a full analysis. Read a complete report — every page, no email required.

引擎如何处理这个问题

This question routes to Go-to-Market & Commercial Strategy, one of 29 engagements the platform runs. For B2B SaaS公司 it works through net revenue retention, CAC payback, ACV by segment and gross margin, then produces the sequence rather than a list of options — which move first, what it funds, and the observation that would say the sequence is wrong.

You watch the analysis get built before paying anything. 在此阅读完整报告 if you would rather see the depth first.

人们关于此问题的常见提问

合理的获客成本是多少?

唯一有意义的检验是与生命周期价值和回本期对比,而这两者都因业务而异。对一种模式很好的成本,在另一个收入相同的模式里可能是致命的。

判断一个渠道需要多久?

长到覆盖你的销售周期再加一个回本期,不能再长。判断太早会杀死慢生效的渠道;判断太晚会继续资助永不回本的渠道。

现金紧张时应该砍营销吗?

先砍无法衡量的渠道——风险集中在那里。均匀砍掉会把正在起效的渠道和没起效的一起去掉。

Is this different in b2b saas than in other industries?

Materially, yes. Growth has fallen from 42% to 32% while 60% of revenue sits in the segment with the worst economics — which changes both the diagnosis and the order of the fixes. The metrics that decide it here are net revenue retention, CAC payback, ACV by segment, and an answer built on industry-general benchmarks will usually point at the wrong one first.

What data do I need before this analysis is worth running for a B2B SaaS company?

Less than most people expect. Your last twelve months of revenue and cost split the way you already split it, plus whatever you hold on net revenue retention and CAC payback. The analysis is explicit about what it is assuming where your data stops, which is more useful than waiting for numbers you may never have.

When is Percision the wrong tool?

Percision is the wrong tool if you already know the answer and only need execution capacity, or if the business is pre-revenue — then the constraint is evidence about the market, not analysis of your own figures. Percision is not a lawyer, tax advisor, auditor, licensed appraiser, clinical or regulatory filer, or an AI implementation shop. It does not do HR casework, creative-only brand work, or impersonate a named consulting firm. It is a strategy analysis engine — not a template library. Also wrong if you need facilitation, politics, or someone to sit with a lender or buyer. Those are human jobs.

Does Percision replace a lawyer, tax advisor, auditor, or AI implementation team?

Percision is not a lawyer, tax advisor, auditor, licensed appraiser, clinical or regulatory filer, or an AI implementation shop. It does not do HR casework, creative-only brand work, or impersonate a named consulting firm. It is a strategy analysis engine — not a template library.

这是你业务中的情况吗?

Describe the situation in your own words and we will tell you which analysis answers it — before you sign up for anything.

Describe my situation →

Prefer to skip ahead? Go straight to the free diagnostic.

English · Español · Deutsch · Português · Français · Italiano · Nederlands · 日本語 · 한국어 · 中文 · Polski · Svenska · Türkçe · العربية · Tiếng Việt · ไทย · हिन्दी · עברית